A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

被引:0
|
作者
Rudolph M. Navari
Lawrence H. Einhorn
Patrick J. Loehrer
Steven D. Passik
Jake Vinson
John McClean
Naveed Chowhan
Nasser H. Hanna
Cynthia S. Johnson
机构
[1] University of Notre Dame,Notre Dame Cancer Institute
[2] Indiana University School of Medicine South Bend,Division of Hematology
[3] Indiana University Medical Center,Oncology
[4] Indiana University Cancer Center,Division of Biostatistics
[5] Memorial Sloan-Kettering Cancer Center,undefined
[6] Hoosier Oncology Group,undefined
[7] Medical and Surgical Specialists,undefined
[8] Cancer Care Center,undefined
[9] Indiana University School of Medicine,undefined
来源
Supportive Care in Cancer | 2007年 / 15卷
关键词
Olanzapine; Palonosetron; Dexamethasone; Chemotherapy; Anti-emetic therapy; Delayed emesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer
    Navari, Rudolph M.
    FUTURE ONCOLOGY, 2010, 6 (07) : 1073 - 1084
  • [22] Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 722 : 180 - 186
  • [23] Phase II Study on EANI Combined with Hydrochloride Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting Following Highly Emetogenic Chemotherapy
    Xiao, Yang
    Liu, Jun
    Liu, Yang-Chen
    Huang, Xin-En
    Guo, Jian-Xong
    Wei, Wei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (09) : 3951 - 3954
  • [24] Palonosetron for the treatment of chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2599 - 2608
  • [25] Olanzapine for Chemotherapy-Induced Nausea and Vomiting
    Bossaer, John B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14): : 1395 - 1396
  • [26] Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
    Lijun Tan
    Jiangtao Liu
    Xiuli Liu
    Jie Chen
    Zhijun Yan
    Huifen Yang
    Daxin Zhang
    Journal of Experimental & Clinical Cancer Research, 28
  • [27] A modifed olanzapine regimen for the prevention of chemotherapy-induced nausea and vomiting
    Sorooshian, Hormozan
    Vo, Long
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (11): : 388 - 391
  • [28] Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
    Tan, Lijun
    Liu, Jiangtao
    Liu, Xiuli
    Chen, Jie
    Yan, Zhijun
    Yang, Huifen
    Zhang, Daxin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [29] Budget impact of netupitant/palonosetron for the prevention of chemotherapy-induced nausea and vomiting
    Park, Sang Hee
    Binder, Gary
    Corman, Shelby
    Botteman, Marc
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (08) : 840 - 847
  • [30] Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting (CINV): A randomized phase III trial
    Navari, R. M.
    Gray, S. E.
    Kerr, A. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)